DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,155 | -9.7% | 248 | 0.0% | 0.00% | – |
| Q2 2023 | $3,492 | -8.9% | 248 | 0.0% | 0.00% | – |
| Q1 2023 | $3,832 | -5.7% | 248 | 0.0% | 0.00% | – |
| Q4 2022 | $4,065 | -18.7% | 248 | -2.7% | 0.00% | – |
| Q3 2022 | $5,000 | +66.7% | 255 | +2.8% | 0.00% | – |
| Q2 2022 | $3,000 | – | 248 | +651.5% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 33 | -95.1% | 0.00% | – |
| Q4 2021 | $7,000 | +133.3% | 674 | +674.7% | 0.00% | – |
| Q3 2021 | $3,000 | – | 87 | +770.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 10 | -71.4% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 35 | +250.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 10 | -75.0% | 0.00% | – |
| Q3 2020 | $2,000 | -50.0% | 40 | -41.2% | 0.00% | – |
| Q2 2020 | $4,000 | – | 68 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |